Colombia vs Kiribati: Death rate from cancer
Colombia
88.96 deaths per 100,000 people
in 2021
Kiribati
85.23 deaths per 100,000 people
in 2021
Colombia rank
101st
Kiribati rank
104th
Death rate from cancer over time
- Colombia
- Kiribati
How they compare
Colombia currently reports 88.96 deaths per 100,000 people against 85.23 deaths per 100,000 people in Kiribati, a difference of 3.73 deaths per 100,000 people.
Across all 22 years both countries report, Colombia has been ahead every year.
Colombia ranks 101st and Kiribati ranks 104th of 194 countries.
Colombia has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Colombia | Kiribati | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 73.93 deaths per 100,000 people | 66.43 deaths per 100,000 people | 7.51 deaths per 100,000 people | Colombia |
| 2010s | 84.1 deaths per 100,000 people | 70.47 deaths per 100,000 people | 13.63 deaths per 100,000 people | Colombia |
| 2020s | 89.91 deaths per 100,000 people | 80.64 deaths per 100,000 people | 9.27 deaths per 100,000 people | Colombia |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher death rate from cancer, Colombia or Kiribati?
- Colombia, at 88.96 deaths per 100,000 people against 85.23 deaths per 100,000 people in Kiribati as of 2021.
- What is the difference in death rate from cancer between Colombia and Kiribati?
- 3.73 deaths per 100,000 people, with Colombia ahead.
- How many years of comparable data are there for Colombia and Kiribati?
- 22 years are reported by both, from 2000 to 2021.
- How do Colombia and Kiribati rank globally for death rate from cancer?
- Colombia ranks 101st and Kiribati ranks 104th of 194 countries.
- Where does this data come from?
- World Health Organization (2024) – with major processing by Our World in Data, published as Death rate from cancer. Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Estimated number of deaths from malignant neoplasms in both sexes, per 100,000 people.